VolitionRx Limited (VNRX) Q3 2022 Earnings Call Transcript

VolitionRx Limited (NYSE:NYSE:VNRX) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM Company Participants Scott Powell - IR Cameron Reynolds - Founder, Group CEO Tom Butera - CEO,...

Related Keywords

Germany ,New York ,United States ,Taiwan ,Netherlands ,United Kingdom ,Texas ,Singapore ,Belgium ,China ,Portugal ,France ,London ,City Of ,American ,Scott Powell ,Michael Okunewitch ,Sharon Ballesteros ,Bruce Jackson ,Steven Ralston ,Tom Butera ,Cameron Reynolds ,Jerome Benoit ,Terig Hughes ,Company Participants ,International Society On Thrombosis ,Texas Gi Lab ,European Society Of Veterinary Oncologist ,Maxim Group ,Gi Lab ,University Of Namur ,Heska Corporation ,European Veterinary Oncology Group ,Volitionrx Limited ,University Of Texas Md Anderson Cancer Center ,International Symposium ,Drug Administration ,Exchange Commission ,National Screening Program ,National University Of Taiwan ,St Thoma University Hospital London ,Welcome To Volitionrx Limited Third Quarter ,Conference Call November ,Third Quarter ,Executive Vice President ,Chief Executive Officer ,Volition Veterinary ,Chief Financial ,Private Securities Litigation Reform Act ,Volition Vet ,Heska Cooperation ,Veterinary Diagnostic ,New York Pet ,Clinical Director ,European Society ,Veterinary Oncologist ,Andrew Aswani ,Neutrophil Extracellular Traps ,Nucleosome Biomarkers ,Septic Shock ,Observational Studies ,International Society ,United States Food ,Cancer Center ,Hospices Civils De Lyon ,Lung Cancer Screening ,Sage Healthcare ,National Screening ,Chief Medical Officer ,London Vet Show ,National University ,